Navigation Links
Smoking during pregnancy may impair thyroid function of mom and fetus
Date:1/13/2009

Chevy Chase, MDCigarette smoking during pregnancy is associated with potentially harmful changes in both maternal and fetal thyroid function, according to a new study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM).

"We studied the influence of cigarette smoking on thyroid function of two groups of women at different stages of pregnancy one in the first trimester and the other in the third trimester," said Dr. Bijay Vaidya, Ph.D., of Peninsula Medical School at Royal Devon and Exeter Hospital in the United Kingdom, and coauthor of the study. "In both groups we found that smoking during pregnancy is associated with changes in the mothers' thyroid hormone levels."

Optimal maternal thyroid function during pregnancy is vital for a successful pregnancy outcome, said Dr. Vaidya. The adverse outcomes associated with thyroid dysfunction during pregnancy include increased risk of miscarriage, premature birth, low birth weight and impaired neuropsychological development of the baby.

Dr. Vaidya and his colleagues also measured thyroid hormone levels in the umbilical cord of babies born to smoking mothers and found that smoking-related changes in thyroid function extend to the fetus. Dr. Vaidya believes that impaired thyroid function in the fetus could have potentially harmful biological consequences.

The study also found that in mothers who stopped smoking during pregnancy their thyroid hormone levels were comparable to levels found in non-smokers, which suggests that changes in thyroid function are rapidly reversible.

There is currently no definitive explanation for how smoking affects thyroid function, but Dr. Vaidya suggests that smoking may influence thyroid hormone levels by affecting the enzyme which converts the active form of thyroid hormone to an inactive form.


'/>"/>

Contact: Aaron Lohr
alohr@endo-society.org
240-482-1380
The Endocrine Society
Source:Eurekalert

Page: 1

Related biology news :

1. Smoking turns on genes -- permanently
2. Girls who begin dieting twice as likely to start smoking
3. Climate -- no smoking gun for Neanderthals
4. Cigarette smoking may accelerate disability in those with MS
5. New research explains link between smoking and SIDS
6. First trimester smoking linked to oral clefts
7. Muscle mass: Scientists identify novel mode of transcriptional regulation during myogenesis
8. Low vitamin D during pregnancy linked to pre-eclampsia
9. Amazon forest shows unexpected resiliency during drought
10. Intravenous gene therapy protects normal tissue of mice during whole-body radiation
11. Moms obesity during conception phase may set the stage for offsprings obesity risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2016)... , April 27, 2016 ... the  "Global Multi-modal Biometrics Market 2016-2020"  report to ... ) , The analysts forecast the ... CAGR of 15.49% during the period 2016-2020.  ... number of sectors such as the healthcare, BFSI, ...
(Date:4/14/2016)... BioCatch ™, the global ... the appointment of Eyal Goldwerger as CEO. ... Goldwerger,s leadership appointment comes at a time of significant ... of its platform at several of the world,s largest ... unique cognitive and physiological factors, is a winner of ...
(Date:3/29/2016)... March 29, 2016 LegacyXChange, Inc. ... "LEGX" and SelectaDNA/CSI Protect are pleased to announce our ... in a variety of writing instruments, ensuring athletes signatures ... created collectibles from athletes on LegacyXChange will be assured ... the DNA. Bill Bollander , CEO ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... 2016  Liquid Biotech USA ... a Sponsored Research Agreement with The University of ... from cancer patients.  The funding will be used ... with clinical outcomes in cancer patients undergoing a ... be employed to support the design of a ...
(Date:6/24/2016)... SAN DIEGO , June 24, 2016 /PRNewswire/ ... that more sensitively detects cancers susceptible to PARP ... individual circulating tumor cells (CTCs). The new test ... of HRD-targeted therapeutics in multiple cancer types. ... therapies targeting DNA damage response pathways, including PARP, ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... release of its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering ... retention in this eBook by providing practical tips, tools, and strategies for clinical ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT has ... Ontario biotechnology company, Propellon Therapeutics Inc. ... and commercialization of a portfolio of first-in-class WDR5 ... targets such as WDR5 represent an exciting class ... in precision medicine for cancer patients. Substantial advances ...
Breaking Biology Technology: